Flier Jeffrey S
Department of Medicine and Department of Neurobiology, Harvard Medical School, Boston, Massachusetts.
Endocr Rev. 2019 Feb 1;40(1):1-16. doi: 10.1210/er.2018-00179.
Insulin and leptin are critical metabolic hormones that play essential but distinct roles in regulating the physiologic switch between the fed and starved states. The discoveries of insulin and leptin, in 1922 and 1994, respectively, arose out of radically different scientific environments. Despite the dearth of scientific tools available in 1922, insulin's discovery rapidly launched a life-saving therapy for what we now know to be type I diabetes, and continually enhanced insulin therapeutics are now effectively applied to both major forms of this increasingly prevalent disease. In contrast, although the discovery of leptin provided deep insights into the regulation of central nervous system energy balance circuits, as well as an effective therapy for an extremely rare form of obesity, its therapeutic impact beyond that has been surprisingly limited. Despite an enormous accumulated body of information, many important questions remain unanswered about the mechanisms of action and role in disease of both hormones. Additionally, although many decades apart, both discoveries reveal the complexities inherent to scientific collaboration and the assignment of credit, even when the efforts are spectacularly successful.
胰岛素和瘦素是关键的代谢激素,在调节进食和饥饿状态之间的生理转换中发挥着重要但不同的作用。胰岛素和瘦素分别于1922年和1994年被发现,它们产生于截然不同的科学环境。尽管在1922年可用的科学工具匮乏,但胰岛素的发现迅速推出了一种拯救生命的疗法,用于治疗我们现在所知的I型糖尿病,并且不断改进的胰岛素疗法现在有效地应用于这种日益普遍的疾病的两种主要形式。相比之下,尽管瘦素的发现为中枢神经系统能量平衡回路的调节提供了深刻见解,以及为一种极其罕见的肥胖症提供了有效疗法,但其除此之外的治疗影响却出人意料地有限。尽管积累了大量信息,但关于这两种激素的作用机制和在疾病中的作用,许多重要问题仍未得到解答。此外,尽管相隔数十年,但这两项发现都揭示了科学合作以及功劳归属所固有的复杂性,即使这些努力取得了巨大成功。